Literature DB >> 12731006

Efficient central nervous system remyelination requires T cells.

Allan J Bieber1, Scott Kerr, Moses Rodriguez.   

Abstract

We demonstrate a role for immune functions in the spontaneous remyelination of central nervous system (CNS) axons after lysolecithin-induced demyelination in the spinal cord. Rag-1-deficient mice lack both B cells and T cells and show significantly reduced spontaneous remyelination compared with control mice of matching genetic background. Mice lacking or depleted of either CD4(+) T cells or CD8(+) T cells also exhibit reduced remyelination. These data indicate that T cells are necessary for efficient CNS remyelination. Thus, general nonspecific immunosuppression as a therapeutic approach for the treatment of CNS injury and demyelinating disease may have undesirable effects on subsequent tissue repair.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12731006     DOI: 10.1002/ana.10578

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  60 in total

1.  The relevance of animal models in multiple sclerosis research.

Authors:  Aleksandar Denic; Aaron J Johnson; Allan J Bieber; Arthur E Warrington; Moses Rodriguez; Istvan Pirko
Journal:  Pathophysiology       Date:  2011-02

2.  Intrathecal effects of daclizumab treatment of multiple sclerosis.

Authors:  B Bielekova; N Richert; M L Herman; J Ohayon; T A Waldmann; H McFarland; R Martin; G Blevins
Journal:  Neurology       Date:  2011-11-09       Impact factor: 9.910

Review 3.  Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Authors:  Kelly A Chamberlain; Sonia E Nanescu; Konstantina Psachoulia; Jeffrey K Huang
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

Review 4.  Remyelination strategies: new advancements toward a regenerative treatment in multiple sclerosis.

Authors:  Martin Stangel; Corinna Trebst
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

5.  Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis.

Authors:  Oleg Butovsky; Gennady Landa; Gilad Kunis; Yaniv Ziv; Hila Avidan; Nadav Greenberg; Adi Schwartz; Igor Smirnov; Ayala Pollack; Steffen Jung; Michal Schwartz
Journal:  J Clin Invest       Date:  2006-03-23       Impact factor: 14.808

Review 6.  Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair.

Authors:  Chengrui An; Yejie Shi; Peiying Li; Xiaoming Hu; Yu Gan; Ruth A Stetler; Rehana K Leak; Yanqin Gao; Bao-Liang Sun; Ping Zheng; Jun Chen
Journal:  Prog Neurobiol       Date:  2013-12-26       Impact factor: 11.685

7.  Tumor necrosis factor alpha is reparative via TNFR2 [corrected] in the hippocampus and via TNFR1 [corrected] in the striatum after virus-induced encephalitis.

Authors:  Moses Rodriguez; Laurie Zoecklein; Louisa Papke; Jeff Gamez; Aleksandar Denic; Slobodan Macura; Charles Howe
Journal:  Brain Pathol       Date:  2008-04-15       Impact factor: 6.508

Review 8.  The benefits of neuroinflammation for the repair of the injured central nervous system.

Authors:  Heather Y F Yong; Khalil S Rawji; Samira Ghorbani; Mengzhou Xue; V Wee Yong
Journal:  Cell Mol Immunol       Date:  2019-03-15       Impact factor: 11.530

9.  Activation of inflammatory response by a combination of growth factors in cuprizone-induced demyelinated brain leads to myelin repair.

Authors:  Juan Carlos Biancotti; Shalini Kumar; Jean de Vellis
Journal:  Neurochem Res       Date:  2008-07-26       Impact factor: 3.996

10.  CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis.

Authors:  Chandra Deb; Reghann G Lafrance-Corey; William F Schmalstieg; Brian M Sauer; Huan Wang; Christopher L German; Anthony J Windebank; Moses Rodriguez; Charles L Howe
Journal:  PLoS One       Date:  2010-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.